Tenderwize
Back to tender search

Open House Discount Agreements Amifampridin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 320 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Amifampridin, ATC N07XX05

40/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Enter into non-exclusive discount agreements for the pharmaceutical active substance Amifampridin (ATC N07XX05) with AOK Bayern.
  • Agreements are based on a standardized, non-negotiable contract template.
Show full summary

This notice describes an open house model (not a competitive procurement) for non-exclusive pharmaceutical discount agreements on the active substance Amifampridin (ATC N07XX05) by AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract term. The agreement period is from 01.09.2025 to 31.08.2027, with contracts possible until 03.07.2027. There is no selection process; all qualifying companies that submit the required documents will be accepted. No estimated value is provided. The tender is open only to pharmaceutical companies, and all documents must be in German.

Risks

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Proof of authorization (commercial register extract or power of attorney) for signatories.

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Submission of a completed and signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria - open house model; any qualified company may join.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Discount Agreements Amifampridin

Open house model for discount agreements on Amifampridin (ATC N07XX05). Any qualifying pharmaceutical company may join. Contracts start on the first of the month following submission (if submitted by the 3rd). No competitive selection; all eligible participants are accepted. Contract duration 01.09.2025-31.08.2027.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Award Criteria

No award criteria - open house model; any qualified company may join.

Deadline

Deadline Jul 03, 2027

Procurement Details

Publication date
13 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
456857-2025

Documents (2)

Similar tenders